C

Clarity Pharmaceuticals Ltd
ASX:CU6

Watchlist Manager
Clarity Pharmaceuticals Ltd
ASX:CU6
Watchlist
Price: 3.36 AUD 5.33% Market Closed
Market Cap: 1.3B AUD

Wall Street
Price Targets

CU6 Price Targets Summary
Clarity Pharmaceuticals Ltd

Wall Street analysts forecast CU6 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CU6 is 7.55 AUD with a low forecast of 5.05 AUD and a high forecast of 9.66 AUD.

Lowest
Price Target
5.05 AUD
50% Upside
Average
Price Target
7.55 AUD
125% Upside
Highest
Price Target
9.66 AUD
188% Upside
Clarity Pharmaceuticals Ltd Competitors:
Price Targets
INVA
Innoviva Inc
67% Upside
053030
Binex Co Ltd
85% Upside
KLBF
Kalbe Farma Tbk PT
42% Upside
JNJ
Johnson & Johnson
3% Upside
MVP
Medical Developments International Ltd
65% Upside
MOB
Moberg Pharma AB (publ)
32% Upside
CPH
Cipher Pharmaceuticals Inc
22% Upside
000538
Yunnan Baiyao Group Co Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Clarity Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Clarity Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat

Net Income
Forecast

Net Income Estimate
Clarity Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CU6's stock price target?
Price Target
7.55 AUD

According to Wall Street analysts, the average 1-year price target for CU6 is 7.55 AUD with a low forecast of 5.05 AUD and a high forecast of 9.66 AUD.

Back to Top